Fiammetta Romano

Dr. Fiammetta Romano

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2020 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
FRFiammetta Romano
Fiammetta Romano
Giovanna MuscogiuriGiovanna Muscogiuri
Giovanna Muscogiuri
EBElea Di Benedetto
Elea Di Benedetto
VZVohla V.. V Zhukouskaya
Vohla V.. V Zhukouskaya
Luigi BarreaLuigi Barrea
Luigi Barrea
CSCarolina Di somma
Carolina Di somma
Background: Vitamin D exerts multiple pleiotropic effects beyond its role in calcium-phosphate metabolism. Growing evidence suggests an association between hypovitaminosis D and sleep disorders, thus increasing the interest in the role of this vitamin in the regulatory mechanisms of the sleep-wake cycle. Objective: The study aimed to explore and summarize the current knowledge about the role of vitamin D in sleep regulation and the impact of vitamin D deficiency on sleep disorders. Methods: The main regulatory mechanisms of vitamin D on sleep are explained in this study. The literature was scanned to identify clinical trials and correlation studies showing an association between vitamin D deficiency and sleep disorders. Results: Vitamin D receptors and the enzymes that control their activation and degradation are expressed in several areas of the brain involved in sleep regulation. Vitamin D is also involved in the pathways of production of Melatonin, the hormone involved in the regulation of human circadian rhythms and sleep. Furthermore, vitamin D can affect sleep indirectly through non-specific pain disorders, correlated with alterations in sleep quality, such as restless legs syndrome and obstructive sleep apnea syndrome. Conclusions: : Vitamin D has both a direct and an indirect role in the regulation of sleep. Although vitamin D deficiency has been associated to sleep disorders, there is still scant evidence to concretely support the role of vitamin D supplementation in the prevention or treatment of sleep disturbances; indeed, more intervention studies are needed to better clarify these aspects.

1 July 2016 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
PDF file
FRFiammetta Romano
Fiammetta Romano
CHCailin R. Heinze
Cailin R. Heinze
LBL.G. Barber
L.G. Barber
JMJoel Bernard Mason
Joel Bernard Mason
LFLisa M. Freeman
Lisa M. Freeman
Background: In humans and rodents obesity appears to promote some cancers by increasing incidence, tumor aggressiveness, recurrence, and fatality. However, the relationship between obesity and cancer in dogs has not been thoroughly evaluated. Hypothesis/Objectives: Whether body condition score (BCS) at the time of lymphoma (LSA) or osteosarcoma (OSA) diagnosis in dogs is predictive of survival time (ST) or progression-free interval (PFI). We hypothesized that an overweight body state at the time of cancer diagnosis would be associated with negative outcomes. Animals: Dogs with LSA (n = 270) and OSA (n = 54) diagnosed and treated between 2000 and 2010. Methods: Retrospective case review. Signalment, body weight, BCS, cancer diagnosis and treatment, relevant clinicopathologic values, and survival data were collected. Dogs were grouped by BCS (underweight, ideal, and overweight) and ST and PFI were compared. Results: Overall, 5.5% of dogs were underweight, 54.0% were ideal weight, and 40.4% were overweight at diagnosis. Underweight dogs with LSA had shorter ST (P = .017) than ideal or overweight dogs. BCS was not associated with ST for OSA (P = .474). Progression-free interval did not differ among BCS categories for either cancer. Conclusions and Clinical Importance: Obesity was not associated with adverse outcomes among dogs with LSA or OSA in this retrospective study; however, being underweight at the time of diagnosis of LSA was associated with shorter survival. More research is needed to elucidate the relationship between excessive body weight and cancer development and progression in dogs.

24 August 2023 in Frontiers in Endocrinology
Verified
Journal Article
Open access
FRFiammetta Romano
Fiammetta Romano
DSDomenico Serpico
Domenico Serpico
MCMariateresa Cantelli
Mariateresa Cantelli
ASAntonella Di Sarno
Antonella Di Sarno
CDCarmine Dalia
Carmine Dalia
CSCarolina Di Somma
Carolina Di Somma
Osteoporosis (OP) and Dermatoporosis (DP) are expressions of the aging process at the skin and bone levels, respectively. Both conditions are associated with increased morbidity for elderly people, and this requires necessary interventions. They share many common risk factors; among these, vitamin D (VD) deficiency appears to have a role. VD is involved in either disease with many mechanisms, among which immunomodulation. VD deficiency has been linked to OP because it inhibits the body’s capacity to absorb calcium and maintain optimal bone health. Available evidence suggests that proper vitaminosis D also appears to be vital in preventing skin age-related issues. DP is often seen in elderly individuals, particularly those with long-term sun exposure and a history of chronic sun damage. VD deficiency can be linked to DP, since its involvement in collagen production, epidermal barrier function, inflammation regulation, wound healing, and sun protection. Aim of this review is to summarize the most updated existing evidence on the role of VD in the development of fragility syndromes such as DP and OP and the possible benefits of VD supplementation as a simple and harmful weapon against aging.

28 September 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
CSCarolina Di somma
Carolina Di somma
ESElisabetta Scarano
Elisabetta Scarano
Luigi BarreaLuigi Barrea
Luigi Barrea
Domenico SolariDomenico Solari
Domenico Solari
EREnrico Riccio
Enrico Riccio
Annamaria ColaoAnnamaria Colao
Annamaria Colao
Aim: To investigate the potential association among Craniopharyngioma (CP), chronotypes and metabolic risk profile. Subjects and Methods: The study population included 28 patients (46.4% males; 42.6 ± 15.8 years) and 28 controls, age, gender and BMI matched (46.4% males; 46.5 ± 12.9 years). In this study sample, we evaluated: anthropometric measurements (waist circumference, WC; BMI), plasma glucose, lipid profile, and systolic (SBP) and diastolic (DBP) blood pressure. Morningness-Eveningness was measured with the Horne-Ostberg Morningness-Eveningness Questionnaire (MEQ), which included 19 questions about preferred sleep time and daily performance. Results: in both patients and controls grade I obesity was detected in 15 subjects (53.6%), grade II obesity in 13 subjects (46.4%). In the patient group, the mean score of chronotype was 47.8 ± 12.6. In particular, 9 patients (32.1%) exhibited the morning chronotype, 6 (21.4%) the intermediate chronotype and 13 (46.4.%) the evening chronotype. No significant difference was found in gender and age among the chronotype categories. Patients with the evening chronotype had higher blood pressure values and worse metabolic parameters than those with the morning chronotype. In the control group, the mean score of the chronotype was 57.6 ± 9.5. In particular, 16 (57.1%) subjects exhibited the morning chronotype, 10 (35.7%) the intermediate chronotype and only 2 (7.1.%) the evening chronotype. The prevalence of intermediate and evening chronotypes was higher in females than males (p = 0.021), while males have a higher prevalence of the morning chronotype. Subjects with intermediate and evening chronotypes had worse metabolic parameters than those with the morning chronotype. In patients, the chronotype score was inversely correlated to WC, BMI, SBP, DBP, plasma glucose, total cholesterol, triglycerides, LDL cholesterol and positively correlated with HDL cholesterol. No correlation was found between age and chronotype. In controls, the chronotype score was inversely correlated to WC, BMI, plasma glucose, total cholesterol, LDL cholesterol. No correlation was found among chronotype and age, blood pressure, triglycerides, HDL cholesterol. Considering the whole population of the study (patients and controls), at logistic regression the chronotype score was significantly associated with the presence of CP. Conclusions: for the first time thus far, our study puts the light on the association of the CP with chronotypes and metabolic alterations in this disease, which are the main determinants of the reduced quality of life, higher morbidity and mortality in this setting of patients. This finding suggests that alterations of chronotype might represent an adjunctive risk for CP patients and a possible target for their integrate management.

13 January 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
CSCarolina Di somma
Carolina Di somma
ESElisabetta Scarano
Elisabetta Scarano
AAArianna Arianna
Arianna Arianna
FRFiammetta Romano
Fiammetta Romano
MLMariarosaria Lavorgna
Mariarosaria Lavorgna
Annamaria ColaoAnnamaria Colao
Annamaria Colao
Experimental studies support the hypothesis that GH/IGF-1 status may influence neoplastic tissue growth. Epidemiological studies suggest a link between GH/IGF-1 status and cancer risk. However, several studies regarding GH replacement safety in childhood cancer survivors do not show a prevalence excess of de novo cancers, and several reports on children and adults treated with GH have not shown an increase in observed cancer risk in these patients. The aim of this review is to provide an at-a-glance overview and the state of the art of long-term effects of GH replacement on neoplastic risk in adults with growth hormone deficiency who have survived cancer and sellar tumors.

1 January 2022 in Minerva Endocrinology
Verified
Journal Article
Closed access
FRFiammetta Romano
Fiammetta Romano
EBElea DI Benedetto
Elea DI Benedetto
ESElisabetta Scarano
Elisabetta Scarano
EREnrico Riccio
Enrico Riccio
RARossana Arianna
Rossana Arianna
CSCarolina DI Somma
Carolina DI Somma
Article: Treatment of Paget’s disease of the bone: long-term effect of neridronate in a real-life setting - Minerva Endocrinology 2021 December;46(4):374-83 - Minerva Medica - Journals